Skip to content

CG肿瘤制药

US · CGON #1929 按市值排名 上市于 2024
59.85 -2.01 -3.25%
实时 - 追踪5344个代码 - 心跳于491秒前 · 2026-10-16 19:30

✦ 量化股权信号 计算方式说明

减持
  • 最近一期（2026/Q3）披露持股的机构数量减少了2家。
  • 机构持股总比例下降了1.9个百分点。

机构持股

机构持股比例
116.10% -1.93pp
机构数量
299 -2
数据截至
2026/Q3 较上一报告期

持股变动 vs 资金流向

方向一致

机构在上一报告期减持了股份，同时该股在最近20个交易日的主力资金呈净流出——两者方向一致。

机构持股变动数据按季度发布且存在滞后；资金流向数据为每日更新。请将其作为方向性的交叉验证参考，而非精确的择时信号。

持股人类型

Mutual Fund62.34%
VC/PE Fund26.79%
Hedge Fund18.81%
Public Company4.46%
Private Company3.21%
Individual/Insider0.92%
Government Pension Fund0.27%
Insurance Company0.21%

主要股东 截至 2026-06-30

T. Rowe Price Group, Inc. 11.76% · 10.42M 股
RTW Investments, LP 9.61% · 8.51M 股
Decheng Capital LLC 7.19% · 6.37M 股
BlackRock 7.06% · 6.26M 股
Wellington Management Group 6.01% · 5.32M 股
Longitude Capital Management Co., LLC 5.26% · 4.66M 股
FMR 4.69% · 4.16M 股
Vanguard Capital Management, LLC 4.35% · 3.86M 股
TCG Crossover Management, LLC 4.14% · 3.67M 股
ORI Capital 3.94% · 3.49M 股

条形长度是相对于此处列出的最大股东而言，并非相对于公司100%股权。

内部人持股

共追踪50份申报 · 14次买入 · 36次卖出

姓名职务持股比例
Hong Fang Song Independent Director 0.69%
Arthur Kuan Chairperson & CEO 0.22%
Corleen Roche Chief Financial Officer 0.00%
Vijay Kasturi Chief Medical Officer 0.00%
Leonard Post Lead Independent Director --
James DeTore Interim Principal Financial & Accounting Officer --
Victor Tong Independent Director --
Ambaw Bellete President --
Susan Graf Independent Director --
ORI Capital -- --

内部人交易 最近的 Form 4 申报记录

日期姓名职务类型股数价格
2026-09-20 Ambaw Bellete President Intent to Sell (Form 144) -30,787 $76.01
2026-09-16 Ambaw Bellete President Intent to Sell (Form 144) -6,532 $76.50
2026-09-14 Leonard Post Lead Independent Director Derivative Exercise and Sale -1,000 $0.60–72.98
2026-09-10 Ambaw Bellete President Intent to Sell (Form 144) -826 $75.00
2026-09-01 Ambaw Bellete President Intent to Sell (Form 144) -29,630 $77.61
2026-08-30 Ambaw Bellete President Intent to Sell (Form 144) -50,000 $75.51
2026-08-26 Ambaw Bellete President Intent to Sell (Form 144) -5,789 $79.39
2026-08-24 Ambaw Bellete President Intent to Sell (Form 144) -10,551 $79.55
2026-08-23 Ambaw Bellete President Intent to Sell (Form 144) -5,762 $79.52
2026-08-18 Ambaw Bellete President Intent to Sell (Form 144) -100,000 $79.54
2026-08-16 Ambaw Bellete President Intent to Sell (Form 144) -52,438 $76.95
2026-08-13 Leonard Post Lead Independent Director Derivative Exercise and Sale -1,000 $0.60–74.54
2026-08-13 Ambaw Bellete President Intent to Sell (Form 144) -19,364 $75.02
2026-08-12 Ambaw Bellete President Intent to Sell (Form 144) -25,989 $75.95
2026-08-11 Ambaw Bellete President Intent to Sell (Form 144) -32,137 $78.62
2026-08-10 Ambaw Bellete President Intent to Sell (Form 144) -50,000 $76.21
2026-08-09 Ambaw Bellete President Intent to Sell (Form 144) -50,000 $75.41
2026-08-06 Ambaw Bellete President Intent to Sell (Form 144) -9,250 $75.25
2026-08-05 Ambaw Bellete President Intent to Sell (Form 144) -75,000 $75.63
2026-08-04 Ambaw Bellete President Intent to Sell (Form 144) -25,000 $73.50

Form 4 申报记录，每家公司显示最新的一批。"Other Derivative Acquisition"（其他衍生品获取）类目多为限制性股票/期权归属，并非公开市场买入——具体类型见"类型"列。

报价时间 2026-10-16 19:30:04 · 仅供参考，不构成投资建议，也未考虑您的具体情况。

CG肿瘤制药 讨论区 0 条评论

发表评论